Pertussis Maternal Immunization Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 9, 2015

Study Completion Date

December 9, 2015

Conditions
Pregnant Women
Interventions
BIOLOGICAL

Tdap

0.5 mL IM once at visit #2

BIOLOGICAL

Td

0.5 mL IM once at visit #2

Trial Locations (1)

B3K 6R8

Clinical Trial Research Center - Canadian Center for Vaccinology, Halifax

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

IWK Health Centre

OTHER

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

Scott Halperin

OTHER